+48 510 897 570
contact@cancer-rnr.eu
Innovative gold complexes with CN group as anticancer agents – possible mechanisms of action
Szymon Lipiec, Przemysław Szymański, Agata Gurba, Łukasz Szeleszczuk, Przemysław Taciak, Jakub Fichna, Izabela Młynarczuk-Biały
p. 4-14
The role of liquid biopsy in lung cancer – from detection to disease control
Szymon Musik, Mariusz Panczyk
p. 15-22
Emperipolesis in neuroendocrine tumors of the thymus
Ewelina Jałonicka, Paulina Zegarska, Eliza Mędrek, Natalia Matusiak, Aleksandra Stangret
p. 23-34
Insulinoma-associated protein 1 (INSM1) – new nuclear marker of neuroendocrine differentiation with high sensitivity and specificity in immunohistochemical diagnostics of neuroendocrine neoplasms – review
Elżbieta Czykier, Miłosz Nesterowicz
p. 35-49
Analysis of brain tumor emission spectra in patients treated surgically
Kamila Woźniak-Dąbrowska
p. 50-61
New trends in glioblastoma multiforme immunotherapy
Natalia Kurowska, Marcel Madej, Barbara Strzałka-Mrozik
p. 62-72
Prevention of cervical cancer in Poland before and during the COVID-19 pandemic
Małgorzata Drężek-Skrzeszewska, Ewa Kupcewicz
p. 73-78
The role of epithelial-mesenchymal transition in the progression of pancreatic and colorectal malignancies
Marta Fudalej, Daria Kwaśniewska, Anna Badowska-Kozakiewicz, Andrzej Deptała
p. 79-83
Low-carbohydrate diet in glioblastoma treatment – mechanism of action and safety
Ewelina Polak-Szczybyło, Magdalena Zielińska, Grzegorz Sobek, Agnieszka Ewa Stępień
p. 84-91
Changes in skin physiology in patients during cancer treatment
Klaudia Mazurek, Ewa Pierzchała, Magdalena Skrzypiec, Alicja Bielecka
p. 92-100